+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of heparin-induced prolongation of APTT in 12 different laboratories in Kyushu area



Comparison of heparin-induced prolongation of APTT in 12 different laboratories in Kyushu area



Rinsho Byori. Japanese Journal of Clinical Pathology 61(7): 576-582



APTT is widely used for serial monitoring of treatment with unfractionated heparin. However, since its sensitivity to heparin varies significantly from one reagent to another, it is suggested that the therapeutic range had to be defined for each brand of APTT reagents. In this study, to investigate the affect of these variables, we compared various reagents of APTT and instruments for APTT measurements in different laboratories of university hospitals and related hospitals in Kyushu area. Same sample of normal pooled plasma added unfractionated heparin were measured in each laboratory. Prolongation of APTT by unfractionated heparin differed between laboratories. In addition, we examined prolongation of APTT by unfractionated heparin in normal plasma obtained from single donor. The prolongation of APTT differed between single donor samples even in the using of single APTT reagent and instrument. No correlation was observed between prolongation ratio of APTT and antithrombin concentration. These results indicate that sensitivity to heparin varies between individual in addition to brand of APTT reagent.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052235456

Download citation: RISBibTeXText

PMID: 24205697


Related references

In vitro modeling of the influence of FVIII activity and heparin induced prolongation of APTT. Bosnian Journal of Basic Medical Sciences 5(3): 26-29, 2005

Comparison of two APTT methods of monitoring heparin therapy. APTT ratio and heparin response of pooled normal plasma. American Journal of Clinical Pathology 93(5): 684-689, 1990

An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. Clinical Chemistry and Laboratory Medicine 53(10): 1593-1603, 2015

Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents. Thrombosis Research 129(5): 666-667, 2012

Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. European Journal of Pharmacology 635(1-3): 165-170, 2010

Monitoring heparin treatment with the APTT: The effect of methodological changes on the APTT. Netherlands Journal of Medicine 49(1): 13-18, 1996

Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening. European Journal of Haematology 96(6): 578-585, 2016

Heparin sensitivity comparison of the act sct and aptt. Anesthesiology 71(3A): A4, 1989

Comparison of unfractionated heparin low molecular weight heparin and their international standard aptt heptest anti iia and anti xa activity. Blut 60(2): 117, 1990

Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT. American Journal of Clinical Pathology 94(3): 297-306, 1990

Comparison of standard heparin APTT range with enoxaparin in the TIMI 11B trial. Blood 94(10 Suppl. 1 Part 2): 88b, 1999

A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin. Pathology 33(3): 347-352, 2001

Use of anti-X a activity as a marker for heparin-induced bleeding in patients with APTT > 180 s. Clinical Chemistry 43(9): 1781-1782, 1997

A low molecular weight heparin kabi 2165 fragmin in repeated use for hemodialysis prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin. Nephrology Dialysis Transplantation 5(2): 135-140, 1990